デフォルト表紙
市場調査レポート
商品コード
1063450

末梢血管向け塞栓保護装置(心血管) - 世界市場の分析と予測モデル

Peripheral Embolic Protection Devices (Cardiovascular) - Global Market Analysis and Forecast Model

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.31円
末梢血管向け塞栓保護装置(心血管) - 世界市場の分析と予測モデル
出版日: 2022年01月21日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、末梢血管向け塞栓保護装置(心血管)市場について調査し、新型コロナウイルス感染症(COVID-19)が同市場に与える2020年以降の影響の詳細、業界動向、2015年から2030年までの市場展望、SWOT分析、競合情勢、地域別、国別の分析など、包括的な情報を提供しています。

レポートの概要

末梢血管向け塞栓保護装置市場の現状と進化する競合情勢

  • 主要な業界動向の洞察レビュー
  • 末梢血管向け塞栓保護装置市場の年間総収益と市場展望:セグメント別(2015年~2030年)
  • 総処置数、単位、平均販売価格、市場価値に関する詳細なデータ:セグメント別

世界、地域、国レベルの市場洞察

  • 末梢血管向け塞栓保護装置市場のSWOT分析
  • 末梢血管向け塞栓保護装置市場に関する競争力学の洞察と動向
  • 医療制度の概要:国別
  • 償還政策:国別
  • 医療技術に関する規制状況:国別

対象企業:Medtronic plc、Abbott Laboratories、Boston Scientific Corp、Cardinal Health Inc、Allium Medical Solutions Ltd

対象国:米国、英国、ドイツ、フランス、イタリア、スペイン、ブラジル、中国、インド、ロシア、日本、オーストラリア、カナダ、メキシコ、韓国、デンマーク、アイルランド、オランダ、ニュージーランド、南アフリカ、スウェーデン、スイス、オーストリア、ベルギー、フィンランド、イスラエル、ノルウェー、ポーランド、ポルトガル、台湾、チェコ共和国、ギリシャ、ハンガリー、トルコ、エジプト、サウジアラビア、アラブ首長国連邦、アルゼンチン、チリ

目次
Product Code: GDME671MM

Peripheral Embolic Protection Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Peripheral Embolic Protection Devices market for the year 2020 and beyond. A narrowing of arteries due to the build-up of plaque occurs in conditions such as peripheral vascular disease, carotid artery stenosis and renal artery stenosis. Angioplasty is a minimally invasive interventional procedure that is used to unblock an artery with excessive plaque build-up in order to restore normal blood flow. Embolic debris may become dislodged during angioplasty procedures, which if left alone can cause a pulmonary embolism. To protect against distal embolic events, EPD are designed to capture and remove debris that may get dislodged during interventional procedures. Present technologies for Embolic Protection Devices (EPD) employ three important strategies: distal occlusion, proximal occlusion and distal filtration.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Peripheral Embolic Protection Devices market and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Peripheral Embolic Protection Devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Peripheral Embolic Protection Devices market.
  • Competitive dynamics insights and trends provided Peripheral Embolic Protection Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Medtronic plc, Abbott Laboratories, Boston Scientific Corp, Cardinal Health Inc, Allium Medical Solutions Ltd

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Peripheral Embolic Protection Devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Peripheral Embolic Protection Devices market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Peripheral Embolic Protection Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Peripheral Embolic Protection Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Peripheral Embolic Protection Devices market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.